# Molecular pattern of acquiring upper respiratory infection

**Authors:** Mohamed A. Hendaus

PMC · DOI: 10.3389/fmed.2026.1768374 · Frontiers in Medicine · 2026-02-06

## TL;DR

This paper explores how cold environments weaken the body's natural defenses against respiratory viruses, increasing infection risk in winter.

## Contribution

The paper introduces evidence that cold temperatures reduce the effectiveness of antimicrobial extracellular vesicles in mucosal defenses.

## Key findings

- Exposure to cold environments weakens antimicrobial extracellular vesicles (EVs) in the mucus.
- Biological factors, not just indoor crowding, contribute to increased respiratory infections in winter.
- Mucosal defenses are critical in fighting infections but are compromised in cold conditions.

## Abstract

Upper respiratory tract infections (URIs) are a significant public health concern. Human behavior plays a crucial role in how often infected individuals come into contact with susceptible individuals. Among the key factors influencing the seasonality of these infections, variations in temperature and absolute humidity are critical elements driving the increase in respiratory virus infections, particularly during the winter months. Traditionally, it has been believed that cold and flu viruses thrive in winter mainly because falling temperatures lead to people spending more time indoors, which facilitates easier transmission. However, compelling evidence suggests that biological factors also contribute to the increased risk of illness in colder weather. Recent studies indicate that active mucosal defenses against bacteria extend into the mucus itself, aided by the epithelial release of antimicrobial extracellular vesicle (EV) swarms. Unfortunately, these studies have also shown that EVs are significantly weakened by exposure to cold environments.

## Full-text entities

- **Genes:** DYRK1A (dual specificity tyrosine phosphorylation regulated kinase 1A) [NCBI Gene 1859] {aka DYRK, DYRK1, HP86, MNB, MNBH, MRD7}, TLR3 (toll like receptor 3) [NCBI Gene 7098] {aka CD283, IIAE2, IMD83}
- **Diseases:** throat dryness (MESH:D014987), wheezing (MESH:D012135), bronchiolitis (MESH:D001988), viral infections (MESH:D014777), coughing (MESH:D003371), leukocytosis (MESH:D007964), bronchitis (MESH:D001991), cardiovascular diseases (MESH:D002318), infected (MESH:D007239), immune- (MESH:D007154), COPD (MESH:D029424), pneumonia (MESH:D011014), respiratory disorders (MESH:D012131), throat irritation (MESH:C538390), microbial infections (MESH:D015163), disorders (MESH:D009358), otitis media (MESH:D010033), flu (MESH:D007251), immune impairment (MESH:D020274), sinusitis (MESH:D012852), inflammatory (MESH:D007249), URIs (MESH:D012141), injury (MESH:D014947), swelling (MESH:D004487), asthma (MESH:D001249), shortness of breath (MESH:D004417), irritation (MESH:D001523), Alzheimer's disease (MESH:D000544), cancerous (MESH:D009369)
- **Chemicals:** lipids (MESH:D008055), catecholamines (MESH:D002395), norepinephrine (MESH:D009638), aldosterone (MESH:D000450), epinephrine (MESH:D004837), cortisol (MESH:D006854)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** G93A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12920469/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12920469/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12920469/full.md

---
Source: https://tomesphere.com/paper/PMC12920469